selected publications
- Evaluation and Treatment of Constipation in the Geriatric Population. Clinics in geriatric medicine. 2020 Information Resource GET IT
-
Impact of patient and disease characteristics on the efficacy and safety of eluxadoline for IBS-D: a subgroup analysis of phase III trials.
Therapeutic advances in gastroenterology.
2019
Academic Article
GET IT
Times cited: 15 -
An Open-Label Pilot Study of Duloxetine in Patients With Irritable Bowel Syndrome and Comorbid Major Depressive Disorder.
Journal of clinical psychopharmacology.
2016
Academic Article
GET IT
Times cited: 17 -
Current and emergent pharmacologic treatments for irritable bowel syndrome with diarrhea: evidence-based treatment in practice.
Therapeutic advances in gastroenterology.
2016
Information Resource
GET IT
Times cited: 34 -
Measuring symptoms in the irritable bowel syndrome: development of a framework for clinical trials.
Alimentary pharmacology & therapeutics.
2010
Academic Article
GET IT
Times cited: 52 -
Characterizing abdominal pain in IBS: guidance for study inclusion criteria, outcome measurement and clinical practice.
Alimentary pharmacology & therapeutics.
2010
Academic Article
GET IT
Times cited: 30 -
Measuring irritable bowel syndrome patient-reported outcomes with an abdominal pain numeric rating scale.
Alimentary pharmacology & therapeutics.
2009
Academic Article
GET IT
Times cited: 93 -
Developing valid and reliable health utilities in irritable bowel syndrome: results from the IBS PROOF Cohort.
The American journal of gastroenterology.
2009
Academic Article
GET IT
Times cited: 61 - Gastroenterology Expert Column - Diagnosing irritable bowel syndrome: What's too much, what's enough?. MedGenMed Medscape General Medicine. 2004 Article
-
Diagnosing irritable bowel syndrome: what's too much, what's enough?.
MedGenMed : Medscape general medicine.
2004
Academic Article
GET IT
Times cited: 8